Hepatocyte Growth Factor in Blood and Gastric Cancer Risk: A Nested Case-Control Study.

Jieun JangSeung Hyun MaKwang-Pil KoBo Yul ChoiKeun-Young YooSue-Kyung Park

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)

These findings suggest HGF as a useful biomarker to predict gastric cancer risk. Further research to assess gastric cancer risk based on useful biomarkers, including HGF, may contribute to primary prevention of gastric cancer.

Keyphrases

growth factor
liver injury
case control
drug induced